State microbe is noteworthy because it is: the first significant antibiotic discovered after penicillin; the first systemic antibiotic discovered in America; the first antibiotic active against tuberculosis; first-line treatment for plague. Moreover, New Jersey was the home of Selman Waksman, who was awarded the Nobel Prize in Physiology or Medicine for his systematic studies of antibiotic production by "S. griseus" and other soil microbes. On May 15, 2017, Senate Bill 3190 (S3190) was introduced by Senator Samuel D. Thompson (R-12); the bill designates "Streptomyces griseus" as the New Jersey State Microbe, to be added to the state's other state symbols. On June
Antibiotic and antifungals treating life-threatening infections based on smaller clinical trials. The CDC will monitor the use of antibiotics and the emerging resistance, and publish the data. The FDA antibiotics labeling process, 'Susceptibility Test Interpretive Criteria for Microbial Organisms' or 'breakpoints', will provide accurate data to healthcare professionals. According to Allan Coukell, senior director for health programs at The Pew Charitable Trusts, "By allowing drug developers to rely on smaller datasets, and clarifying FDA's authority to tolerate a higher level of uncertainty for these drugs when making a risk/benefit calculation, ADAPT would make the clinical trials more feasible." Antibiotic An antibiotic